Anonymised, illustrative composite. A disciplinary finding against an owner does not instantly destroy a pharmacy business. It starts a fuse on the corporation's compliance with the share and director tests — and it disqualifies the individual immediately, which is a different rule with different timing.
At a glance
A pharmacist-owned regional group was five weeks into exclusivity on a two-store corporation owned by three pharmacists: two founders on 30% each of the common and preferred, and a third on 40% of each, who also held one of the three board seats. The third shareholder had been the reason the business came to market. The founders described it as a wish to simplify the ownership.
It was not. A Discipline Committee panel had revoked his certificate of registration, and the founders had known for eleven weeks. See managing confidentiality during a live process for why a vendor tells you late; the more useful question is what the lateness costs.
A revocation against an owner sounds like the end of the business, and the buyer's first instinct was to walk. The Drug and Pharmacies Regulation Act says otherwise, and it says it with a clock attached. Section 144(2): “For the purposes of the ownership of a pharmacy, or for the purposes of the composition of the board of directors or ownership of shares of a corporation as required by section 142, the right to operate the pharmacy shall not be affected by, (a) any suspension of the certificate of registration of a pharmacist; or (b) the revocation of the certificate of registration of a pharmacist until after a period of six months has elapsed.”
Note what that subsection protects and what it does not. It preserves the corporation's right to operate notwithstanding that one of the pharmacists whose registration made the s.142 majorities work is no longer registered. It does not preserve anything for the individual. Section 143 does the opposite, and does it immediately: “No person whose certificate of registration has been revoked for cause or while his or her licence is suspended for cause, (a) shall be employed or work in a pharmacy; or (b) shall act as a director or vote as a shareholder in a corporation operating a pharmacy.”
So on the day of the revocation the corporation was still lawfully operating both stores, and the third shareholder was already unable to sit as a director or vote his 40% blocks. A three-person board was functionally a two-person board, and a shareholder vote that needed his shares could not be held.
Eleven weeks of the twenty-six had run before the buyer learned of it. Fifteen weeks were left. The buyer's original timetable to signing and closing was thirteen weeks, which left two weeks of margin on a transaction that had already produced one surprise.
Total consideration was $6,600,000: $2,640,000 for the 40% block and $3,960,000 for the founders' 60%, of which $600,000 was held back. The holdback was not a general indemnity retention. It was sized against one identified risk — that the corporation would not have restored a pharmacist majority of each class and of the board before the six months elapsed — and its release condition was evidence of that restoration, not the passage of time.
The right question is not whether the vendor is in trouble. It is when the six months started, because that date is the only one that matters and neither party's instinct is to volunteer it.
The distinction between the two limbs of s.144(2) shaped the sequencing. Paragraph (a) — suspension — carries no time limit at all: the right to operate is simply not affected for as long as the suspension lasts. Paragraph (b) — revocation — carries the six-month fuse. A buyer told only that there is a disciplinary matter has been told nothing useful. Suspension and revocation are different facts with different consequences, and the difference is the presence or absence of a deadline.
The buyer also had to make sure the transaction itself did not breach s.142 on the way to fixing it. The buyer was a pharmacist-owned corporation holding a valid certificate of authorization, so acquiring the 40% blocks put those shares back into a holder of the kind s.142(2) requires — owned by and registered in the name of a qualifying holder. Had the buyer been an investor rather than a pharmacist-owned entity, the same purchase would have converted a temporary compliance problem into a permanent one.
On the board, the vacated seat had to be filled by a pharmacist to keep the majority of the directors pharmacists under s.142(1). That was done by appointment before closing rather than as a closing deliverable, because s.142(1) is a continuing condition and the corporation was operating throughout.
The transaction was re-sequenced into two steps nine weeks apart, both inside the remaining fifteen. The 40% blocks were bought first, which simultaneously removed the disqualified shareholder and restored an unambiguous pharmacist majority of each class. The founders' 60% followed, with the $600,000 holdback released on delivery of an updated share register and evidence of the reconstituted board.
The price moved by less than the buyer expected. What it paid for was speed, and the founders had no realistic alternative process inside fifteen weeks.
If the six months had elapsed with the share register unchanged, the corporation would have stopped satisfying s.142(2) and, through s.144(1), would have ceased to be a person permitted to own or operate either pharmacy. Both stores' certificates of accreditation would have been exposed under s.140, where the Discipline Committee's orders include revocation, suspension, and a fine of not more than $100,000. Directors are separately exposed under s.166(2).
The realistic commercial outcome is worse than the statutory one: a two-store business that has to sell inside a published deadline, to a buyer who can count the weeks.
The tell was a shareholder exiting for a stated reason that did not match his economics — the largest single holder, in a profitable business, selling first and fastest. The follow-up question is not what the disciplinary history is; it is what the exact effective date of any suspension or revocation is, because s.144(2)(b) runs from it and nothing else on the file does.
The second tell was a board that had stopped passing resolutions. Where s.143 disqualifies a director from acting, the minute book records the absence before anybody explains it.
A 30-minute call is enough to tell you whether AI pays for itself here.
Canadian small-business transaction data is not published anywhere, so most valuations in this country quote an American benchmark. The Deavo–Treadstone Acquisition Index is a daily record of Canadian listings built to replace that: asking-price distributions by province and city are published now, and days on market, departure rates and asking-to-sale spreads follow as the series lengthens. Leave an email and we will tell you as each measure lands.
No pitch, no listings. One email when the first report lands.
